Literature DB >> 35654975

A multiancestry genome-wide association study of unexplained chronic ALT elevation as a proxy for nonalcoholic fatty liver disease with histological and radiological validation.

Marijana Vujkovic1,2, Shweta Ramdas3, Daniel J Rader2,3, Benjamin F Voight4,5,6,7, Kyong-Mi Chang8,9, Kim M Lorenz1,3,10, Xiuqing Guo11, Rebecca Darlay12, Heather J Cordell12, Jing He13, Yevgeniy Gindin14, Chuhan Chung14, Robert P Myers14,15, Carolin V Schneider3, Joseph Park2,3, Kyung Min Lee16, Marina Serper1,2, Rotonya M Carr17, David E Kaplan1,2, Mary E Haas18, Matthew T MacLean3, Walter R Witschey19, Xiang Zhu20,21,22,23, Catherine Tcheandjieu20,24, Rachel L Kember25,26, Henry R Kranzler25,26, Anurag Verma1,3, Ayush Giri27, Derek M Klarin20,28,29, Yan V Sun30,31, Jie Huang32, Jennifer E Huffman33, Kate Townsend Creasy3, Nicholas J Hand3, Ching-Ti Liu34, Michelle T Long35, Jie Yao11, Matthew Budoff36, Jingyi Tan11, Xiaohui Li11, Henry J Lin11, Yii-Der Ida Chen11, Kent D Taylor11, Ruey-Kang Chang11, Ronald M Krauss37, Silvia Vilarinho38, Joseph Brancale38, Jonas B Nielsen39, Adam E Locke39, Marcus B Jones39, Niek Verweij39, Aris Baras39, K Rajender Reddy2, Brent A Neuschwander-Tetri40, Jeffrey B Schwimmer41, Arun J Sanyal42, Naga Chalasani43, Kathleen A Ryan44, Braxton D Mitchell44, Dipender Gill45, Andrew D Wells46,47, Elisabetta Manduchi3, Yedidya Saiman48, Nadim Mahmud49, Donald R Miller50,51, Peter D Reaven52,53, Lawrence S Phillips30,54, Sumitra Muralidhar55, Scott L DuVall16,56, Jennifer S Lee20,24, Themistocles L Assimes20,24,57, Saiju Pyarajan33,58,59, Kelly Cho33,58,59, Todd L Edwards60,61, Scott M Damrauer1,3,62, Peter W Wilson30,63, J Michael Gaziano33,58, Christopher J O'Donnell33,58,59, Amit V Khera29,59,64, Struan F A Grant3,65,66, Christopher D Brown3, Philip S Tsao20,24,57, Danish Saleheen67,68,69, Luca A Lotta39, Lisa Bastarache13, Quentin M Anstee70,71, Ann K Daly71, James B Meigs29,59,72, Jerome I Rotter11, Julie A Lynch16,56,73.   

Abstract

Nonalcoholic fatty liver disease (NAFLD) is a growing cause of chronic liver disease. Using a proxy NAFLD definition of chronic elevation of alanine aminotransferase (cALT) levels without other liver diseases, we performed a multiancestry genome-wide association study (GWAS) in the Million Veteran Program (MVP) including 90,408 cALT cases and 128,187 controls. Seventy-seven loci exceeded genome-wide significance, including 25 without prior NAFLD or alanine aminotransferase associations, with one additional locus identified in European American-only and two in African American-only analyses (P < 5 × 10-8). External replication in histology-defined NAFLD cohorts (7,397 cases and 56,785 controls) or radiologic imaging cohorts (n = 44,289) replicated 17 single-nucleotide polymorphisms (SNPs) (P < 6.5 × 10-4), of which 9 were new (TRIB1, PPARG, MTTP, SERPINA1, FTO, IL1RN, COBLL1, APOH and IFI30). Pleiotropy analysis showed that 61 of 77 multiancestry and all 17 replicated SNPs were jointly associated with metabolic and/or inflammatory traits, revealing a complex model of genetic architecture. Our approach integrating cALT, histology and imaging reveals new insights into genetic liability to NAFLD.
© 2022. This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35654975     DOI: 10.1038/s41588-022-01078-z

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   41.307


  100 in total

Review 1.  The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases.

Authors:  Naga Chalasani; Zobair Younossi; Joel E Lavine; Michael Charlton; Kenneth Cusi; Mary Rinella; Stephen A Harrison; Elizabeth M Brunt; Arun J Sanyal
Journal:  Hepatology       Date:  2017-09-29       Impact factor: 17.425

Review 2.  Burden of liver diseases in the world.

Authors:  Sumeet K Asrani; Harshad Devarbhavi; John Eaton; Patrick S Kamath
Journal:  J Hepatol       Date:  2018-09-26       Impact factor: 25.083

Review 3.  Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention.

Authors:  Zobair Younossi; Quentin M Anstee; Milena Marietti; Timothy Hardy; Linda Henry; Mohammed Eslam; Jacob George; Elisabetta Bugianesi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-09-20       Impact factor: 46.802

Review 4.  Nonalcoholic Fatty Liver Disease: Pathophysiology and Management.

Authors:  Rotonya M Carr; Amanke Oranu; Vandana Khungar
Journal:  Gastroenterol Clin North Am       Date:  2016-10-13       Impact factor: 3.806

5.  Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma.

Authors:  John C Chambers; Weihua Zhang; Joban Sehmi; Xinzhong Li; Mark N Wass; Pim Van der Harst; Hilma Holm; Serena Sanna; Maryam Kavousi; Sebastian E Baumeister; Lachlan J Coin; Guohong Deng; Christian Gieger; Nancy L Heard-Costa; Jouke-Jan Hottenga; Brigitte Kühnel; Vinod Kumar; Vasiliki Lagou; Liming Liang; Jian'an Luan; Pedro Marques Vidal; Irene Mateo Leach; Paul F O'Reilly; John F Peden; Nilufer Rahmioglu; Pasi Soininen; Elizabeth K Speliotes; Xin Yuan; Gudmar Thorleifsson; Behrooz Z Alizadeh; Larry D Atwood; Ingrid B Borecki; Morris J Brown; Pimphen Charoen; Francesco Cucca; Debashish Das; Eco J C de Geus; Anna L Dixon; Angela Döring; Georg Ehret; Gudmundur I Eyjolfsson; Martin Farrall; Nita G Forouhi; Nele Friedrich; Wolfram Goessling; Daniel F Gudbjartsson; Tamara B Harris; Anna-Liisa Hartikainen; Simon Heath; Gideon M Hirschfield; Albert Hofman; Georg Homuth; Elina Hyppönen; Harry L A Janssen; Toby Johnson; Antti J Kangas; Ido P Kema; Jens P Kühn; Sandra Lai; Mark Lathrop; Markus M Lerch; Yun Li; T Jake Liang; Jing-Ping Lin; Ruth J F Loos; Nicholas G Martin; Miriam F Moffatt; Grant W Montgomery; Patricia B Munroe; Kiran Musunuru; Yusuke Nakamura; Christopher J O'Donnell; Isleifur Olafsson; Brenda W Penninx; Anneli Pouta; Bram P Prins; Inga Prokopenko; Ralf Puls; Aimo Ruokonen; Markku J Savolainen; David Schlessinger; Jeoffrey N L Schouten; Udo Seedorf; Srijita Sen-Chowdhry; Katherine A Siminovitch; Johannes H Smit; Timothy D Spector; Wenting Tan; Tanya M Teslovich; Taru Tukiainen; Andre G Uitterlinden; Melanie M Van der Klauw; Ramachandran S Vasan; Chris Wallace; Henri Wallaschofski; H-Erich Wichmann; Gonneke Willemsen; Peter Würtz; Chun Xu; Laura M Yerges-Armstrong; Goncalo R Abecasis; Kourosh R Ahmadi; Dorret I Boomsma; Mark Caulfield; William O Cookson; Cornelia M van Duijn; Philippe Froguel; Koichi Matsuda; Mark I McCarthy; Christa Meisinger; Vincent Mooser; Kirsi H Pietiläinen; Gunter Schumann; Harold Snieder; Michael J E Sternberg; Ronald P Stolk; Howard C Thomas; Unnur Thorsteinsdottir; Manuela Uda; Gérard Waeber; Nicholas J Wareham; Dawn M Waterworth; Hugh Watkins; John B Whitfield; Jacqueline C M Witteman; Bruce H R Wolffenbuttel; Caroline S Fox; Mika Ala-Korpela; Kari Stefansson; Peter Vollenweider; Henry Völzke; Eric E Schadt; James Scott; Marjo-Riitta Järvelin; Paul Elliott; Jaspal S Kooner
Journal:  Nat Genet       Date:  2011-10-16       Impact factor: 38.330

6.  Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits.

Authors:  Elizabeth K Speliotes; Laura M Yerges-Armstrong; Jun Wu; Ruben Hernaez; Lauren J Kim; Cameron D Palmer; Vilmundur Gudnason; Gudny Eiriksdottir; Melissa E Garcia; Lenore J Launer; Michael A Nalls; Jeanne M Clark; Braxton D Mitchell; Alan R Shuldiner; Johannah L Butler; Marta Tomas; Udo Hoffmann; Shih-Jen Hwang; Joseph M Massaro; Christopher J O'Donnell; Dushyant V Sahani; Veikko Salomaa; Eric E Schadt; Stephen M Schwartz; David S Siscovick; Benjamin F Voight; J Jeffrey Carr; Mary F Feitosa; Tamara B Harris; Caroline S Fox; Albert V Smith; W H Linda Kao; Joel N Hirschhorn; Ingrid B Borecki
Journal:  PLoS Genet       Date:  2011-03-10       Impact factor: 5.917

Review 7.  Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease.

Authors:  Chris Estes; Homie Razavi; Rohit Loomba; Zobair Younossi; Arun J Sanyal
Journal:  Hepatology       Date:  2017-12-01       Impact factor: 17.425

Review 8.  Genetic predisposition in nonalcoholic fatty liver disease.

Authors:  Silvia Sookoian; Carlos J Pirola
Journal:  Clin Mol Hepatol       Date:  2017-03-09

9.  Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease.

Authors:  Stefano Romeo; Julia Kozlitina; Chao Xing; Alexander Pertsemlidis; David Cox; Len A Pennacchio; Eric Boerwinkle; Jonathan C Cohen; Helen H Hobbs
Journal:  Nat Genet       Date:  2008-09-25       Impact factor: 38.330

10.  A missense variant in Mitochondrial Amidoxime Reducing Component 1 gene and protection against liver disease.

Authors:  Connor A Emdin; Mary E Haas; Amit V Khera; Krishna Aragam; Mark Chaffin; Derek Klarin; George Hindy; Lan Jiang; Wei-Qi Wei; Qiping Feng; Juha Karjalainen; Aki Havulinna; Tuomo Kiiskinen; Alexander Bick; Diego Ardissino; James G Wilson; Heribert Schunkert; Ruth McPherson; Hugh Watkins; Roberto Elosua; Matthew J Bown; Nilesh J Samani; Usman Baber; Jeanette Erdmann; Namrata Gupta; John Danesh; Danish Saleheen; Kyong-Mi Chang; Marijana Vujkovic; Ben Voight; Scott Damrauer; Julie Lynch; David Kaplan; Marina Serper; Philip Tsao; Josep Mercader; Craig Hanis; Mark Daly; Joshua Denny; Stacey Gabriel; Sekar Kathiresan
Journal:  PLoS Genet       Date:  2020-04-13       Impact factor: 5.917

View more
  2 in total

1.  Interactions of physical activity, muscular fitness, adiposity, and genetic risk for NAFLD.

Authors:  Theresia M Schnurr; Sophia Figueroa Katz; Johanne M Justesen; Jack W O'Sullivan; Peter Saliba-Gustafsson; Themistocles L Assimes; Ivan Carcamo-Orive; Aijaz Ahmed; Euan A Ashley; Torben Hansen; Joshua W Knowles
Journal:  Hepatol Commun       Date:  2022-03-15

2.  A minority of somatically mutated genes in pre-existing fatty liver disease have prognostic importance in the development of NAFLD.

Authors:  Jake P Mann; Matthew Hoare
Journal:  Liver Int       Date:  2022-05-11       Impact factor: 8.754

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.